 Home > Active Ingredient News > Study of Nervous System > The first domestic epothilone tumor drug may be born: a new breast cancer class 1 drug "under approval"

The first domestic epothilone tumor drug may be born: a new breast cancer class 1 drug "under approval"

 Last Update: 2021-04-13
 Source: Internet
 Author: User

Tags

anti aging drugs

reach chemical list

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, the review status of utidelone (UTD1)'s new drug marketing application on the NMPA official website was updated to "under approval", or it is expected to be approved for the treatment of recurrent and metastatic advanced breast cancer in the near future .

Breast cancer

If it is successfully approved, it will become the first epothilone anti-tumor drug in China.

Epothilone drugs are broad-spectrum and high-efficiency anti-cancer drugs.

It is understood that the new drug listing application of Utidrolone is based on the results of a prospective, multi-center phase III clinical study.

The specific research data are as follows: For patients with advanced breast cancer who have used anthracyclines and taxanes in the past, the overall survival of Utidrolone combined with capecitabine and capecitabine alone was 15.

At present, anthracyclines and taxanes are still the main drugs used in chemotherapy for advanced breast cancer.

Data for 2020 show that breast cancer has replaced lung cancer as the world's largest cancer.

Diagnose leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin (CNS)

CAS No.: 148553-50-8

Pharmacy Grade

$1/KG FOB

Primidone CAS125-33-7

CAS No.: 125-33-7

Pharmaceutical Grade

$100/KG EXW

API Clomipramine HCl

CAS No.: 17321-77-6

Pharmacy Grade

$40-50/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.